Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Desitrend 1000mg granules sachets
0408010A0BDACAM
|
Desitrend | Levetiracetam | Central Nervous System | 424 |
|
Nicorette Icy White 4mg medicated chewing gum
0410020B0BBAXBD
|
Nicorette | Nicotine | Central Nervous System | 423 |
|
Sodium valproate 250mg MR gran sachets sugar free
0408010W0AABXBX
|
Sodium valproate | Sodium valproate | Central Nervous System | 423 |
|
Adartrel 2mg tablets
0409010H0BCACAC
|
Adartrel | Ropinirole hydrochloride | Central Nervous System | 422 |
|
Meflynate XL 60mg capsules
0404000M0BNAEBA
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 422 |
|
ViePax XL 150mg tablets
0403040W0BIABAK
|
Viepax | Venlafaxine | Central Nervous System | 421 |
|
Buvidal 24mg/0.48ml prolonged-release inj pf syringes
0410030A0BGACAQ
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 419 |
|
Kwells Kids 150microgram tablets
0406000L0BBABAC
|
Kwells | Hyoscine hydrobromide | Central Nervous System | 419 |
|
Nicotine 2mg sublingual tablets sugar free
0410020B0AAAWAW
|
Nicotine | Nicotine | Central Nervous System | 419 |
|
Neurontin 600mg tablets
0408010G0BBADAJ
|
Neurontin | Gabapentin | Central Nervous System | 418 |
|
Buprenorphine 25micrograms/hour transdermal patches
0407020B0AAALAL
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | 416 |
|
Cariprazine 1.5mg capsules
0402010AJAAAAAA
|
Cariprazine | Cariprazine | Central Nervous System | 416 |
|
Methadone 10mg/ml oral solution sugar free
0410030C0AABABA
|
Methadone hydrochloride (Drug Dependence) | Methadone hydrochloride | Central Nervous System | 416 |
|
Depefex XL 75mg capsules
0403040W0BVAAAD
|
Depefex | Venlafaxine | Central Nervous System | 411 |
|
Depefex XL 150mg capsules
0403040W0BVABAE
|
Depefex | Venlafaxine | Central Nervous System | 410 |
|
Relevtec 70micrograms/hour transdermal patches
0407020B0BPACAG
|
Relevtec | Buprenorphine | Central Nervous System | 410 |
|
Sastravi 75mg/18.75mg/200mg tablets
0409010X0BCACAE
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 410 |
|
Neurontin 400mg capsules
0408010G0BBACAC
|
Neurontin | Gabapentin | Central Nervous System | 408 |
|
Ationdo SR 200mg tablets
0407020AGBCAEAF
|
Ationdo | Tapentadol | Central Nervous System | 407 |
|
Reltebon 15mg modified-release tablets
0407020ADBKAFAS
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 407 |
|
Morphine sulfate 20mg/1ml solution for injection ampoules
0407020Q0AAAFAF
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 406 |
|
Syonell 250mg gastro-resistant tablets
0402030Q0BDABAA
|
Syonell | Valproic acid | Central Nervous System | 406 |
|
Tapclob 5mg/5ml oral suspension
040801060BDAACR
|
Tapclob | Clobazam | Central Nervous System | 406 |
|
Reltebon 30mg modified-release tablets
0407020ADBKAGAR
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 402 |
|
Sodium oxybate 500mg/ml oral solution sugar free
0401010ACAAAAAA
|
Sodium oxybate | Sodium oxybate | Central Nervous System | 402 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.